sciXess
sciXess is a dedicated biotech and pharma consulting company based near Munich, Germany, with a mission to support clients in developing and implementing business strategies, licensing, valuation, and rating of innovations and technology-driven companies in the life sciences sector. With over 20 years of experience, sciXess offers hands-on, industry-focused advice to help clients make informed decisions, foster collaborations, and succeed in the competitive biotech and pharmaceutical markets.
Industries
Nr. of Employees
small (1-50)
Patents
Services
Advisory on corporate strategy, portfolio management, gap analysis and strategic business direction.
End-to-end support for in- and out-licensing, partnership identification, negotiation of contracts, and M&A transactions.
Structured rating and valuation services combining financial analysis and qualitative assessment to produce rating reports and value estimates.
Comprehensive technical, financial, IP and legal due diligence including onsite visits and data room review.
Patent strategy development, IP portfolio optimization and IP due diligence support for transactions and financing.
Strategic and operational support after contract closing to implement agreed terms and support integration.
Advisory on corporate strategy, portfolio management, gap analysis and strategic business direction.
End-to-end support for in- and out-licensing, partnership identification, negotiation of contracts, and M&A transactions.
Structured rating and valuation services combining financial analysis and qualitative assessment to produce rating reports and value estimates.
Comprehensive technical, financial, IP and legal due diligence including onsite visits and data room review.
Patent strategy development, IP portfolio optimization and IP due diligence support for transactions and financing.
Strategic and operational support after contract closing to implement agreed terms and support integration.
Expertise Areas
- Biotech and pharmaceutical consulting
- Licensing and technology transfer
- Company and technology valuation
- Due diligence (technical, financial, IP, legal)
Key Technologies
- Qualitative and quantitative rating frameworks
- Discounted cash flow valuation
- Real-option valuation methods
- IP valuation methodologies